Trial · NCT06582732
Registered outcomes14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 14 of 14
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Travoprost Free Acid Concentration (ng/mL) in Aqueous Humor 12 Months Post-administration | month 12 | concentration of travoprost free acid (ng/mL) in the aqueous humor 12 months post-administration as assessed by liquid chromatography tandem mass spectrometry (LC-MS/MS) |
| Primary | Travoprost Free Acid Concentration (ng/mL) in Aqueous Humor 3 Months Post-administration | month 3 | concentration of travoprost free acid (ng/mL) in the aqueous humor 3 months post-administration as assessed by LC-MS/MS |
| Primary | Travoprost Free Acid Concentration (ng/mL) in Aqueous Humor 6 Months Post-administration | month 6 | concentration of travoprost free acid (ng/mL) in the aqueous humor 6 months post-administration as assessed by LC-MS/MS |
| Primary | Travoprost Free Acid Concentration (ng/mL) in Aqueous Humor 24 Months Post-administration | month 24 | concentration of travoprost free acid (ng/mL) in the aqueous humor 24 months post-administration as assessed by LC-MS/MS |
| Primary | Travoprost Free Acid Concentration(ng/mL) in Aqueous Humor 21 Months Post-administration | month 21 | concentration of travoprost free acid (ng/mL) in the aqueous humor 21 months post-administration as assessed by LC-MS/MS |
| Primary | Travoprost Free Acid Concentration (ng/mL) in Aqueous Humor 18 Months Post-administration | month 18 | concentration of travoprost free acid (ng/mL) in the aqueous humor 18 months post-administration as assessed by LC-MS/MS |
| Primary | Travoprost Free Acid Concentration (ng/mL) in Aqueous Humor 15 Months Post-administration | month 15 | concentration of travoprost free acid (ng/mL) in the aqueous humor 15 months post-administration as assessed by LC-MS/MS |
| Secondary | Percent Residual Travoprost in Explanted Implant 12 Months Post-administration | month 12 | percent of travoprost compared to baseline in explanted implant 12 months post-administration as assessed by high performance liquid chromatography (HPLC) |
| Secondary | Percent Residual Travoprost in Explanted Implant 3 Months Post-administration | month 3 | percent of travoprost compared to baseline in explanted implant 3 months post-administration as assessed by HPLC |
| Secondary | Percent Residual Travoprost in Explanted Implant 6 Months Post-administration | month 6 | percent of travoprost compared to baseline in explanted implant 6 months post-administration as assessed by HPLC |
| Secondary | Percent Residual Travoprost in Explanted Implant 24 Months Post-administration | month 24 | percent of travoprost compared to baseline in explanted implant 24 months post-administration as assessed by HPLC |
| Secondary | Percent Residual Travoprost in Explanted Implant 21 Months Post-administration | month 21 | percent of travoprost compared to baseline in explanted implant 21 months post-administration as assessed by HPLC |
| Secondary | Percent Residual Travoprost in Explanted Implant 18 Months Post-administration | month 18 | percent of travoprost compared to baseline in explanted implant 18 months post-administration as assessed by HPLC |
| Secondary | Percent Residual Travoprost in Explanted Implant 15 Months Post-administration | month 15 | percent of travoprost compared to baseline in explanted implant 15 months post-administration as assessed by HPLC |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT06582732/registered